The pharmaceutical packaging market in Taiwan has experienced steady growth over the years, driven by factors such as increasing healthcare expenditure, a growing elderly population, and advancements in pharmaceutical manufacturing technologies. The pharmaceutical packaging market specifically plays a crucial role in ensuring the safety, stability, and delivery of pharmaceutical products. The market includes various packaging types such as bottles, syringes, vials, ampoules, tubes, caps, closures, and labels, tailored to meet the stringent regulatory standards that aim to prevent counterfeits and ensure product integrity.Taiwan Pharmaceutical Packaging Market Forecast till 2030: Set to Reach US$ 1.59 Billion by 2030 with a CAGR of 16.0 %.
Growth Influencers:
The pharmaceutical sector in developing countries like Taiwan is experiencing growth, driven by advancements in manufacturing techniques, technological progress, and increased corporate integration. Taiwan is particularly strong in producing high-value API biologics and injectables, with 59 pharmaceutical contract manufacturing sites, 44 of which are approved by the FDA or EMA and seven by Chinese authorities. Taoyuan leads in pharmaceutical production facilities among special municipalities and counties, accounting for 30% of all sites. Most of these facilities focus on producing API chemicals, with 46% also manufacturing commercial doses. For example, Formosa Laboratories Inc. in Taoyuan produces both API biologics (proteins and peptides) and injectable commercial dosages.The retail pharmacy sector in Taiwan faces increasing competition and potential regulatory changes, which are crucial for ensuring consumer benefits through lower prices and improved services, as well as market consolidation. This rising demand has spurred growth in the pharmaceutical packaging market in Taiwan. Packaging manufacturers are investing heavily in research to develop environmentally friendly and sustainable packaging solutions. The industry aims to meet the demands of healthcare professionals and consumers for products and packaging that are convenient and sustainable.
To enhance sustainability, companies are focusing on using post-consumer recycled (PCR) material and creating biodegradable packaging. Joiepack Industrial specializes in developing and producing automatic packaging equipment, including IV-bag packaging that features a horizontal pillow bag design, providing high performance, reduced downtime, minimized waste, and enhanced operational safety.
Segment Overview:
The Pharmaceutical Packaging market is categorized based on Type and Application.Packaging Type
- Primary
- Secondary
- Tertiary
Product
- Cardboard
- Boxes
- Cartons
Display Unit
- Paper
- Label
- Leaflet
- Glass
- Ampoules
- Bottles
- Vials
- Pre-filled syringes (PFS)
- Cartridges
- Plastic
- Closure
- Bottles
- Bags
- Tubes
- Injection Trays
- Laminates with paper or foil
- Metal
- Collapsible tubes
- Rigid cans
- Foils
- Pressurized containers
- Rubber
- Drug Type
- Oral Drugs
- Injectable
- Topical
- Ocular/ Ophthalmic
- Nasal
- Sublingual
- Pulmonary
- Transdermal
- IV Drugs
- Others
Prescription Type
- Prescription
- Branded drugs
- Generic drugs
- OTC
- Branded drugs
- Generic drugs
End Use
- Pharma Manufacturing
- Contract Packaging
- Retail Pharmacy
- Institutional Pharmacy
Market Segmentation Insights:
In 2023, primary packaging constituted 72.85% of Taiwan's pharmaceutical packaging market. Primary packaging is essential in the pharmaceutical sector as it directly contacts the product, protecting and preserving medicines from contamination while providing crucial information to consumers. Conversely, secondary packaging, which includes cartons, trays, and film bundles, is forecasted to grow at the highest CAGR during the period under review due to its critical role in providing physical protection, barrier protection, regulatory compliance, and patient safety.Regarding materials, plastics held a 37.92% market share in Taiwan's pharmaceTaiwan Pharmaceutical Packaging Market, By Packaging Type (Primary, Secondary and Tertiary); By Product (Cardboard, Paper, Glass, Plastic, Metal, and Rubber); By Application (Oral Drugs, Injectable, Topical, Ocular/ Ophthalmic, Nasal, Sublingual, Pulmonary, Transdermal, IV Drugs and Others); By Prescription Type (Prescription and OTC); By End Use (Pharma Manufacturing, Contract Packaging, Retail Pharmacy and Institutional Pharmacy); By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2030.
Taiwan Pharmaceutical Packaging Market Forecast till 2030: Set to Reach US$ 1.59 Billion by 2030 with a CAGR of 16.0 %.
Market Introduction:
The pharmaceutical packaging market in Taiwan has experienced steady growth over the years, driven by factors such as increasing healthcare expenditure, a growing elderly population, and advancements in pharmaceutical manufacturing technologies. The pharmaceutical packaging market specifically plays a crucial role in ensuring the safety, stability, and delivery of pharmaceutical products. The market includes various packaging types such as bottles, syringes, vials, ampoules, tubes, caps, closures, and labels, tailored to meet the stringent regulatory standards that aim to prevent counterfeits and ensure product integrity.Growth Influencers:
The pharmaceutical sector in developing countries like Taiwan is experiencing growth, driven by advancements in manufacturing techniques, technological progress, and increased corporate integration. Taiwan is particularly strong in producing high-value API biologics and injectables, with 59 pharmaceutical contract manufacturing sites, 44 of which are approved by the FDA or EMA and seven by Chinese authorities. Taoyuan leads in pharmaceutical production facilities among special municipalities and counties, accounting for 30% of all sites. Most of these facilities focus on producing API chemicals, with 46% also manufacturing commercial doses. For example, Formosa Laboratories Inc. in Taoyuan produces both API biologics (proteins and peptides) and injectable commercial dosages.The retail pharmacy sector in Taiwan faces increasing competition and potential regulatory changes, which are crucial for ensuring consumer benefits through lower prices and improved services, as well as market consolidation. This rising demand has spurred growth in the pharmaceutical packaging market in Taiwan. Packaging manufacturers are investing heavily in research to develop environmentally friendly and sustainable packaging solutions. The industry aims to meet the demands of healthcare professionals and consumers for products and packaging that are convenient and sustainable.
To enhance sustainability, companies are focusing on using post-consumer recycled (PCR) material and creating biodegradable packaging. Joiepack Industrial specializes in developing and producing automatic packaging equipment, including IV-bag packaging that features a horizontal pillow bag design, providing high performance, reduced downtime, minimized waste, and enhanced operational safety.
Segment Overview:
The Pharmaceutical Packaging market is categorized based on Type and Application.- Packaging Type
- Primary
- Secondary
- Tertiary
- Product
- Cardboard
- Boxes
- Cartons
- Display Unit
- Paper
- Label
- Leaflet
- Glass
- Ampoules
- Bottles
- Vials
- Pre-filled syringes (PFS)
- Cartridges
- Plastic
- Closure
- Bottles
- Bags
- Tubes
- Injection Trays
- Laminates with paper or foil
- Metal
- Collapsible tubes
- Rigid cans
- Foils
- Pressurized containers
- Rubber
- Application
- Oral Drugs
- Injectable
- Topical
- Ocular/ Ophthalmic
- Nasal
- Sublingual
- Pulmonary
- Transdermal
- IV Drugs
- Others
- Prescription Type
- Prescription
- Branded drugs
- Generic drugs
- OTC
- Branded drugs
- Generic drugs
- End Use
- Pharma Manufacturing
- Contract Packaging
- Retail Pharmacy
- Institutional Pharmacy
Market Segmentation Insights:
In 2023, primary packaging constituted 72.85% of Taiwan's pharmaceutical packaging market. Primary packaging is essential in the pharmaceutical sector as it directly contacts the product, protecting and preserving medicines from contamination while providing crucial information to consumers. Conversely, secondary packaging, which includes cartons, trays, and film bundles, is forecasted to grow at the highest CAGR during the period under review due to its critical role in providing physical protection, barrier protection, regulatory compliance, and patient safety.Regarding materials, plastics held a 37.92% market share in Taiwan's pharmaceutical packaging sector in 2023, attributed to their cost-effectiveness and versatility. Taiwan's healthcare infrastructure advancements, such as the adoption of plastic-based face shields, PPE kits, sanitizer packs, and syringes, support this trend. Meanwhile, the glass segment is expected to see the fastest CAGR growth due to its lower environmental impact and increasing consumer awareness of health risks associated with various packaging materials.
Oral drugs led the market by comprising 30.36% of the share in 2023, driven by the preference for this simple, convenient, and safe administration method. Rising health consciousness and disposable income in Taiwan are also boosting market growth. Additionally, the nasal and pulmonary drug segments are anticipated to expand rapidly due to the increasing prevalence of lung disorders, including lung cancer, which has the highest incidence and mortality rates among cancers in Taiwan.
In terms of prescription type, the prescription segment captured 70.89% of the market share in 2023, fuelled by medical regulations that promote consultations and prescriptions from doctors. However, the Over the Counter (OTC) segment is expected to grow at the highest CAGR, driven by increased awareness of OTC products and higher pharmaceutical spending.
Pharmaceutical manufacturing dominated the market in 2023, holding a 44.69% share, with pharmaceutical companies being the primary consumers of packaging in Taiwan. Market growth is further supported by regional players. Contract manufacturing, as the second-largest segment, is poised for the highest growth rate during the forecast period due to the global rise of Contract Development and Manufacturing Organizations (CDMOs). The growing demand for generic drugs and escalating pharmaceutical R&D activities in Taiwan are likely to propel the growth of the pharmaceutical packaging market, facilitated by the increasing role of CDMOs in speeding up drug development.
Competitive Landscape:
The competitive landscape of the Pharmaceutical Packaging market is characterized by the presence of numerous prominent players driving growth. Key players are Amcor, Taiwan Forever Co., Ltd., Taiwan Liposome Company, Ltd., Kwang Dah Enterprises Co.,Ltd and Inora Pharmaceutical Machinery Co.,Ltd.These companies collectively account for approximately 60% of the market share, indicating robust competition within the sector. Furthermore, many players are actively engaged in research and development activities, partnerships, and collaborations to enhance their market presence and offerings. For instance: in 2020, Amcor broadened its pharmaceutical packaging portfolio by introducing new sustainable laminates and including recyclable high-barrier laminates in its range of pharmaceutical packaging solutions. This illustrates the ongoing efforts within the industry to innovate and offer environmentally conscious packaging options.
Report Insights:
- The Taiwanese pharmaceutical packaging market is projected to reach a value of US$1.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 16.0% from 2024 to 2030.
- In 2023, primary packaging dominated the market, holding a 72.85% share. This type of packaging is crucial as it directly contacts the product, offering protection and preservation against contamination.
- The Over the Counter (OTC) segment is predicted to grow at the highest CAGR, fueled by increased consumer awareness and higher pharmaceutical spending.
- Companies are increasingly focusing on sustainability by using post-consumer recycled materials and developing biodegradable packaging to meet the demands for environmentally friendly options.
Questions to be Answered:
- What is the estimated growth rate of the Taiwan Pharmaceutical Packaging market?
- What are the key drivers and potential restraints?
- Which market segments are expected to witness significant growth?
- Who are the leading players in the market?
Table of Contents
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 4. Taiwan Pharmaceutical Packaging Market Overview
Chapter 5. Taiwan Pharmaceutical Packaging Market, By Packaging Type
Chapter 6. Taiwan Pharmaceutical Packaging Market, By Product
Chapter 7. Taiwan Pharmaceutical Packaging Market, By Application
Chapter 8. Taiwan Pharmaceutical Packaging Market, By Prescription Type
Chapter 9. Taiwan Pharmaceutical Packaging Market, By End Use
Chapter 10. Company Profile (Company Overview, Financial Matrix, Sales Composition Ration, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amcor Limited
- Westrock Company
- Kwang Dah Enterprises Co.,Ltd
- Taiwan Forever Co., Ltd.
- Taiwan Liposome Company, Ltd.
- Inora Pharmaceutical Machinery Co.,Ltd.
- Neostarpack Co., Ltd.
- JENN CHIAN MACHINERY CO.,LTD.
- Mill Powder Tech Solutions
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 127 |
| Published | March 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 0.56 Billion |
| Forecasted Market Value ( USD | $ 1.59 Billion |
| Compound Annual Growth Rate | 16.0% |
| Regions Covered | Taiwan |
